No Data
Cathay Biotech Inc. (688065.SH): A total of 0.23 million shares have been repurchased.
On May 6, Glonghui reported that Cathay Biotech Inc. (688065.SH) has announced that on April 30, 2025, the company repurchased 230,366 shares through the trading system of the Shanghai Exchange via centralized bidding, accounting for 0.0319% of the company's total share capital of 721,289,794 shares. The highest repurchase price was 53.40 yuan/share, the lowest price was 44.08 yuan/share, and the total payment amounted to 10,497,716.71 yuan (excluding stamp duty, transaction commissions, and other trading costs).
Kaiser Biotech: First Quarter 2025 Report
2025 First Quarter Report
Cathay Biotech Inc. (688065.SH): Breakthrough achieved in the molding process of bio-based polyamide continuous fiber composite materials.
On April 22, Gelonghui reported that Cathay Biotech Inc. (688065.SH) stated on the investor interaction platform that the company has made breakthroughs in the forming process of bio-based polyamide continuous fiber composite materials, and has begun to receive commercial Orders in scenarios such as New energy Fund and Logistics. For specific details, please refer to the announcements published by the company on the Shanghai Stock Exchange website.
Cathay Biotech 2024 Profit Up 33%, Revenue Climbs 40%
Kaiser Biotech: 2024 Annual Report Summary
Investors Could Be Concerned With Cathay Biotech's (SHSE:688065) Returns On Capital
